A. Tomova

Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer.

J. von Pawel, G. Ross, Joachim von Pawel, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis.

P. Fasching, F. Couch, K. Gelmon, 2021, European journal of cancer.

An observational, multicentre study of cabazitaxel in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel (CAPRISTANA)

J. Carles, S. Hitier, A. Tomova, 2018, BJU international.

Prospective observational study to evaluate the persistence of treatment with denosumab in patients with bone metastases from solid tumors in routine clinical practice: final analysis

R. Greil, A. Tomova, A. Petzer, 2019, Supportive Care in Cancer.

Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study

R. Greil, I. Diel, A. Tomova, 2022, Supportive Care in Cancer.

Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study

R. Greil, I. Diel, A. Tomova, 2022, Supportive Care in Cancer.

Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine

M. Inbar, C. Wiltschke, T. Brodowicz, 2008 .

Comparable activity with oral topotecan/cisplatin (TC) and IV etoposide/cisplatin (PE) as treatment for chemotherapy-naive patients (pts) with extensive disease small cell lung cancer (ED-SCLC): Final results of a randomized phase III trial (389)

G. Manikhas, J. Eckardt, Z. Pápai, 2005 .

Randomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

M. Socinski, Y. Hotko, J. Singer, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Randomized phase Iii trial of exemestane or tamoxifen in first-line hormonal treatment of postmenopausal women with metastatic breast cancer

A. Eniu, A. Tomova, K. Kalinov, 2007 .

Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine in anthracycline-pretreated metastatic or locally recurrent inoperable breast cancer patients: a prospective multicentre trial of the Central European Cooperative Oncology Group (CECOG)

M. Inbar, C. Wiltschke, T. Brodowicz, 2009, Breast Cancer Research and Treatment.

Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial).

J. S. Lee, D. R. Berry, G. Giaccone, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.